ArticleIndian journal of endocrinology and metabolism

Role of Metformin, Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Orlistat based Multidrug Therapy in Glycemic Control, Weight Loss, and Euglycemia in Diabesity: A Real-World Experience.

Deep Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.